# Future Oncology

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/future-oncology/

## Facts

| Field | Value |
| --- | --- |
| Citations | 99,231 |
| h-index | 111 |
| Homepage | http://www.futuremedicine.com/loi/fon |
| Open Access | false |
| ISSN-L | 1479-6694 |
| ISSNs | 1479-6694,1744-8301 |
| OpenAlex ID | https://openalex.org/S174572715 |
| Publisher | Future Medicine |
| Works | 5,641 |

## Journal papers

Showing 12 of 23.

- [USA Endometrial Cancer Projections to 2030: Should we be Concerned?](https://scholariq.org/papers/usa-endometrial-cancer-projections-to-2030-should-we-be-concerned/)
- [Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma](https://scholariq.org/papers/targeting-the-pi3k-akt-mtor-pathway-in-hepatocellular-carcinoma/)
- [Plasma YKL-40: A Potential New Cancer Biomarker?](https://scholariq.org/papers/plasma-ykl-40-a-potential-new-cancer-biomarker/)
- [Epidemiology, Clinical Manifestations, Risk Reduction and Treatment Strategies of Jaw Osteonecrosis in Cancer Patients Exposed to Antiresorptive Agents](https://scholariq.org/papers/epidemiology-clinical-manifestations-risk-reduction-and-treatment-strategies-of/)
- [Novel Therapeutic Approaches in Chondrosarcoma](https://scholariq.org/papers/novel-therapeutic-approaches-in-chondrosarcoma/)
- [Role of The Epstein–Barr Virus-Encoded Latent Membrane Protein-1, LMP1, in The Pathogenesis of Nasopharyngeal Carcinoma](https://scholariq.org/papers/role-of-the-epstein-barr-virus-encoded-latent-membrane-protein-1-lmp1-in-the/)
- [Mammaprint™: a comprehensive review](https://scholariq.org/papers/mammaprinttm-a-comprehensive-review/)
- [Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA](https://scholariq.org/papers/economic-burden-of-patients-with-diffuse-large-b-cell-and-follicular-lymphoma/)
- [Microwave Ablation of Benign Thyroid Nodules](https://scholariq.org/papers/microwave-ablation-of-benign-thyroid-nodules/)
- [Targeted Agents or Immuno-Oncology Therapies as First-Line Therapy for BRAF-Mutated Metastatic Melanoma: A Real-World Study](https://scholariq.org/papers/targeted-agents-or-immuno-oncology-therapies-as-first-line-therapy-for-braf/)
- [Real-World Genetic Testing Patterns in Metastatic Castration-Resistant Prostate Cancer](https://scholariq.org/papers/real-world-genetic-testing-patterns-in-metastatic-castration-resistant-prostate/)
- [Real-World Homologous Recombination Repair Mutation Testing in Metastatic Castration-Resistant Prostate Cancer in the USA, Europe and Japan](https://scholariq.org/papers/real-world-homologous-recombination-repair-mutation-testing-in-metastatic/)

## Journal top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Gastric Cancer Management and Outcomes](https://scholariq.org/topics/gastric-cancer-management-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.